Adam Bowen - 30 Jun 2023 Form 4 Insider Report for BlueLinx Holdings Inc. (BXC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Jul 2023, 17:10:21 UTC
Prior SEC filing
09 Jun 2023
Next SEC filing
11 Oct 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Brad Resler, as attorney-in-fact for Adam Bowen

Key filing fact

Adam Bowen filed Form 4 for BlueLinx Holdings Inc. (BXC) on 03 Jul 2023.

Key facts

  • This page summarizes Adam Bowen's Form 4 filing for BlueLinx Holdings Inc. (BXC).
  • 3 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 03 Jul 2023, 17:10.

Change

  • Previous filing in this sequence was filed on 09 Jun 2023.
  • Current net transaction value: -$6,283.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BXC transaction

Common Stock

Options Exercise

Transaction value
Shares
+229
Change %
+8.4%
Price
Shares after
2,941
Date
30 Jun 2023
Ownership
Direct
Footnotes
F1, F2
BXC transaction

Common Stock

Tax liability

Transaction value
$6,283
Shares
-67
Change %
-2.3%
Price
$93.78
Shares after
2,874
Date
30 Jun 2023
Ownership
Direct
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BXC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-229
Change %
-33%
Price
$0.000000
Shares after
456
Date
30 Jun 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
229
Exercise price
Footnotes
F1, F2
BXC holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
303
Date
30 Jun 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
303
Exercise price
Footnotes
F2, F4
BXC holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
742
Date
30 Jun 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
742
Exercise price
Footnotes
F2, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Represents the conversion of restricted stock units that vested on June 30, 2023. These are time-based restricted stock units that vest in three equal annual installments commencing on June 30, 2023. Vested shares will be delivered to the reporting person not later than 30 days after the vesting date.

Footnote F2

Each restricted stock unit represents a contingent right to receive one share of BlueLinx Holdings Inc. common stock.

Footnote F3

These shares were withheld to cover tax withholding obligations when 229 time-based restricted stock units vested on June 30, 2023.

Footnote F4

These are time-based restricted stock units that vest in three equal annual installments commencing on June 8, 2022. Vested shares will be delivered to the reporting person that later than 30 days after the vesting date.

Footnote F5

These are time-based restricted stock units that vest in three equal annual installments commencing on June 7, 2024. Vested shares will be delivered to the reporting person not later than 30 days after each vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .